title: The use of fondaparinux in pregnancy.
authors.affiliation: Manchester Medical School, University of Manchester, Manchester, UK.
authors.forename: Esra
authors.initials: E
authors.lastname: Elsaigh
authors.forename: Jecko
authors.initials: J
authors.lastname: Thachil
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Nash
authors.forename: Clare
authors.initials: C
authors.lastname: Tower
authors.forename: Charles R M
authors.initials: CR
authors.lastname: Hay
authors.forename: Sian
authors.initials: S
authors.lastname: Bullough
authors.forename: Louise
authors.initials: L
authors.lastname: Byrd
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D005260:Female; D000077425:Fondaparinux; D006801:Humans; D011134:Polysaccharides / Q000008:administration & dosage*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000517:prevention & control*; D054556:Venous Thromboembolism / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D011134:Polysaccharides; D000077425:Fondaparinux
keywords: allergy; fondaparinux; heparin; pregnancy